Coston McIsaac & Partners’s Avanos Medical AVNS Stock Holding History

Coston McIsaac & Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	8	–	–	﹤0.01%	834
2025 Q4	$0	Sell	8 -5	-38%	-$57	﹤0.01%	827
2025 Q3	$0	Hold	13	–	–	﹤0.01%	789
2025 Q2	$0	Buy	+13	New	+$163	﹤0.01%	758
2025 Q1	–	Sell	-13	Closed	–	–	754
2024 Q4	$0	Hold	13	–	–	﹤0.01%	751
2024 Q3	$0	Hold	13	–	–	﹤0.01%	754
2024 Q2	$0	Hold	13	–	–	﹤0.01%	733
2024 Q1	$0	Hold	13	–	–	﹤0.01%	717
2023 Q4	$0	Hold	13	–	–	﹤0.01%	718
2023 Q3	$0	Hold	13	–	–	﹤0.01%	719
2023 Q2	$0	Hold	13	–	–	﹤0.01%	766
2023 Q1	$0	Buy	13 +8	+160%	+$232	﹤0.01%	796
2022 Q4	$0	Hold	5	–	–	﹤0.01%	766
2022 Q3	$0	Hold	5	–	–	﹤0.01%	685
2022 Q2	$0	Buy	+5	New	+$144	﹤0.01%	474

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Coston McIsaac & Partners's AVNS Position: Q1 2026 in Review

Coston McIsaac & Partners held its Avanos Medical (AVNS) position steady in Q1 2026 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Coston McIsaac & Partners first reported a position in AVNS in Q2 2022 and has held it in 15 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Coston McIsaac & Partners held 8 shares of Avanos Medical worth $0 as of Q1 2026.
Coston McIsaac & Partners left its Avanos Medical share count unchanged in Q1 2026.
Avanos Medical made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q1 2026, its #834 holding.
Coston McIsaac & Partners first reported a position in Avanos Medical in Q2 2022 and has held it in 15 quarters since.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.